Skip to main content
. 2003 Aug 27;23(21):7863–7872. doi: 10.1523/JNEUROSCI.23-21-07863.2003

Figure 8.

Figure 8.

Effect of α-helical-CRH9-41 (αh-CRH 9-41) on MTII-induced suppression of food intake. The treatment groups were as follows: vehicle (Veh) plus vehicle (n = 12); 0.5 nmol of α-helical-CRH9-41 plus vehicle (n = 3); vehicle plus 0.5 nmol of MTII (n = 16); 0.25 nmol of α-helical-CRH9-41 plus 0.5 nmol of MTII (n = 8); and 0.5 nmol of α-helical-CRH9-41 plus 0.5 nmol of MTII (n = 8). Data represent the mean ± SEM, as measured by grams of food intake. +++p < 0.0001; ++p < 0.01 for comparisons with vehicle-vehicle; **p < 0.01; *p < 0.05 for comparisons with vehicle-0.5 nmol of MTII.